Ganga Pharmaceuticals Ltd — Others, 26-08-2025: Others

Ganga Pharmaceuticals will hold its 36th Annual General Meeting for shareholders to approve its annual report. The meeting will cover adopting audited financial results for FY25. For FY25, total income increased to Rs. 3.07 Cr (from Rs. 2.97 Cr last year), and net profit rose to Rs. 0.079 Cr (from Rs. 0.046 Cr). No dividend is proposed, aiming to conserve resources. Key director changes are on the agenda: Mrs. Srijna Sharma for re-appointment, and Mr. Munna Baijnath Chaurasia and Mr. Aman Mukesh Chaudhari for five-year terms as Independent Directors. The company also raised Rs. 1.085 Cr from equity share issuance and Rs. 0.62 Cr from convertible share warrants during the year.